OpenURL Connection Search

Select item for more details and to access through your institution.

Radiation therapy improves survival in rectal small cell cancer - Analysis of Surveillance Epidemiology and End Results (SEER) data.
Published in:
Radiation Oncology, 2015, v. 10, n. 1, p. 1, doi. 10.1186/s13014-015-0411-y
By:
- Modrek, Aram S.;
- Hsu, Howard C.;
- Leichman, Cynthia G.;
- Du, Kevin L.
Publication type:
Article
Radiation therapy improves survival in rectal small cell cancer - Analysis of Surveillance Epidemiology and End Results (SEER) data.
Published in:
Radiation Oncology, 2015, v. 10, n. 1, p. 101, doi. 10.1186/s13014-015-0411-y
By:
- Modrek, Aram S;
- Hsu, Howard C;
- Leichman, Cynthia G;
- Du, Kevin L
Publication type:
Article
Radiation therapy improves survival in rectal small cell cancer - Analysis of Surveillance Epidemiology and End Results (SEER) data.
Published in:
2015
By:
- Modrek, Aram S;
- Hsu, Howard C;
- Leichman, Cynthia G;
- Du, Kevin L
Publication type:
journal article
Challenges posed by non-random missing quality of life data in an advanced-stage colorectal cancer clinical trial.
Published in:
Psycho-Oncology, 2000, v. 9, n. 4, p. 340, doi. 10.1002/1099-1611(200007/08)9:4<340::AID-PON466>3.0.CO;2-F
By:
- Moinpouw, Carol M.;
- Triplett, Julia Sawyers;
- McKnight, Barbara;
- Lovato, Laura C.;
- Upchurch, Christine;
- Leichman, Cynthia G.;
- Muggia, Franco M.;
- Tanaka, Leora;
- Jamesh, Wendy A.;
- Lennard, Martha;
- Meyskens Jr., Frank L.
Publication type:
Article
A fixed-ratio combination of uracil and Ftorafur (UFT) with low dose leucovorin. An active oral regimen for advanced colorectal cancer.
Published in:
1995
By:
- Saltz, Leonard B.;
- Leichman, Cynthia G.;
- Young, Charles W.;
- Muggia, Franco M.;
- Conti, John A.;
- Spiess, Tara;
- Jeffers, Susan;
- Leichman, Lawrence P.;
- Saltz, L B;
- Leichman, C G;
- Young, C W;
- Muggia, F M;
- Conti, J A;
- Spiess, T;
- Jeffers, S;
- Leichman, L P
Publication type:
journal article
Multicenter, randomized phase II trial of bevacizumab plus folinic acid, fluorouracil, gemcitabine (FFG) versus bevacizumab plus folinic acid, fluorouracil, oxaliplatin (FOLFOX4) as first-line therapy for patients with advanced colorectal cancer.
Published in:
Investigational New Drugs, 2012, v. 30, n. 2, p. 772, doi. 10.1007/s10637-010-9598-9
By:
- Madajewicz, Stefan;
- Waterhouse, David M.;
- Ritch, Paul S.;
- Khan, M. Qaseem;
- Higby, Donald J.;
- Leichman, Cynthia G.;
- Malik, Sandeep K.;
- Hentschel, Patricia;
- Gill, John F.;
- Zhao, Luping;
- Nicol, Steven J.
Publication type:
Article
Intergroup Randomized Phase III Study of Postoperative Oxaliplatin, 5‐Fluorouracil, and Leucovorin Versus Oxaliplatin, 5‐Fluorouracil, Leucovorin, and Bevacizumab for Patients with Stage II or III Rectal Cancer Receiving Preoperative Chemoradiation: A Trial of the ECOG‐ACRIN Research Group (E5204)
Published in:
Oncologist, 2020, v. 25, n. 5, p. e798, doi. 10.1634/theoncologist.2019-0437
By:
- Chakravarthy, A. Bapsi;
- Zhao, Fengmin;
- Meropol, Neal J.;
- Flynn, Patrick J.;
- Wagner, Lynne I.;
- Sloan, Jeffrey;
- Diasio, Robert B.;
- Mitchell, Edith P.;
- Catalano, Paul;
- Giantonio, Bruce J.;
- Catalano, Robert B.;
- Haller, Daniel G.;
- Awan, Rashid A.;
- Mulcahy, Mary F.;
- O'Brien, Timothy E.;
- Santala, Roger;
- Cripps, Christine;
- Weis, John R.;
- Atkins, James N.;
- Leichman, Cynthia G.
Publication type:
Article
Phase II Study of Olaparib (AZD-2281) After Standard Systemic Therapies for Disseminated Colorectal Cancer.
Published in:
Oncologist, 2016, v. 21, n. 2, p. 172, doi. 10.1634/theoncologist.2015-0319
By:
- Leichman, Lawrence;
- Groshen, Susan;
- O'Neil, Bert H.;
- Messersmith, Wells;
- Berlin, Jordan;
- Chan, Emily;
- Leichman, Cynthia G.;
- Cohen, Steven J.;
- Cohen, Deirdre;
- Lenz, Heinz‐Josef;
- Gold, Philip;
- Boman, Bruce;
- Fielding, Anitra;
- Locker, Gershon;
- Cason, Ronald C.;
- Hamilton, Stan R.;
- Hochster, Howard S.
Publication type:
Article
Neoadjuvant Doxorubicin/Cyclophosphamide Followed by Ixabepilone or Paclitaxel in Early Stage Breast Cancer and Evaluation of βIII-Tubulin Expression as a Predictive Marker.
Published in:
Oncologist, 2013, v. 18, n. 7, p. 787, doi. 10.1634/theoncologist.2013-0075
By:
- Saura, Cristina;
- Tseng, Ling‐Ming;
- Chan, Stephen;
- Chacko, Raju T.;
- Campone, Mario;
- Manikhas, Alexy;
- Nag, Shona M.;
- Leichman, Cynthia G.;
- Dasappa, Lokanatha;
- Fasching, Peter A.;
- Hurtado de Mendoza, Fernando;
- Symmans, W. Fraser;
- Liu, David;
- Mukhopadhyay, Pralay;
- Horak, Christine;
- Xing, Guan;
- Pusztai, Lajos
Publication type:
Article

Found: 9